Related Articles
Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms
Distinct promoter usage of mdm2 gene in human breast cancer
EFFECTS OF ANTISENSE OLIGONUCLEOTIDES TARGETING K-RAS EXPRESSION IN PANCREATIC-CANCER CELL-LINES
Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild‑type <em>TP53</em> colon and gastric cancer cells with aberrant KRAS signaling